Division of Orthopaedic Surgery, Department of Surgical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.
S Afr Med J. 2020 Mar 30;110(4):320-326. doi: 10.7196/SAMJ.2020.v110i4.14133.
Patients undergoing arthroplasty may have comorbidities that put them at risk of myocardial injury after non-cardiac surgery (MINS). MINS, a new clinical concept that has a different pathophysiology from conventional myocardial infarction, is related to a supply-demand mismatch ischaemia in the perioperative setting. MINS is often a silent event, and the diagnosis relies on cardiac biomarker testing such as troponin T. The incidence is estimated at 40%, with a fourfold increase in morbidity and mortality risk 1 year post surgery.
To determine the prevalence of postoperative troponin leak in a single-centre arthroplasty unit in patients with various cardiac risk factors undergoing hip or knee arthroplasty and investigate the differences in troponin T levels between comorbidities and different types of arthroplasty, i.e. total hip replacement (THR), total knee replacement (TKR) and neck of femur (NoF) fracture hip replacement.
A prospective, cross-sectional study of patients with one or more cardiac risk factors undergoing replacement surgery was conducted from October 2017 to April 2018. Troponin levels of all included patients were recorded on days 1 and 3 post surgery using a high-sensitivity cardiac troponin T assay (Roche hs-cTnT). A level of >15 ng/L is considered abnormal and termed a positive troponin leak, while >100 ng/L is considered suspected acute coronary syndrome (ACS).
One hundred and sixty patients (n=66 THR, n=55 NoF hip replacement, n=39 TKR) were included. Sixty-eight patients (42%) had a positive troponin leak, and in 6 of these cases ACS was suspected. The highest prevalence of troponin leak was recorded in patients undergoing NoF hip replacement (62%), followed by TKR (46%) and then THR (24%). Sixty-two patients (38%) had positive troponin levels on day 1 and 53 patients (33%) had positive levels on day 3. Important patient cardiac risk factors were identified in the presence of a positive troponin leak, with ischaemic heart disease, hypertension, diabetes, renal disease, age >65 years and atrial fibrillation being statistically most likely.
Postoperative troponin surveillance is an inexpensive and reliable way to identify patients at risk of MINS and subsequently enhance early detection, medical optimisation and referral strategies. Simple interventions may improve outcomes and contribute to lower ACS rates and the timeous prevention of other complications. The prevalence of MINS in orthopaedic-specific patients in South Africa (SA) and other resource-constrained developing countries is unknown. Our finding of 42% positive troponin leaks raises awareness of this issue, and we recommend routine postoperative troponin surveillance for all arthroplasty units in SA.
接受关节置换术的患者可能存在合并症,这些合并症使他们在非心脏手术后(MINS)有心肌损伤的风险。MINS 是一个新的临床概念,其病理生理学与传统心肌梗死不同,与围手术期供需不匹配缺血有关。MINS 通常是一个无声的事件,其诊断依赖于心脏生物标志物检测,如肌钙蛋白 T。据估计,其发病率为 40%,术后 1 年发病率和死亡率风险增加 4 倍。
确定在一个单中心关节置换单位中,接受髋关节或膝关节置换术的具有各种心脏危险因素的患者术后肌钙蛋白泄漏的患病率,并研究肌钙蛋白 T 水平在合并症和不同类型关节置换术(全髋关节置换术(THR)、全膝关节置换术(TKR)和股骨颈(NoF)骨折髋关节置换术)之间的差异。
对 2017 年 10 月至 2018 年 4 月期间接受置换手术的具有一个或多个心脏危险因素的患者进行前瞻性、横断面研究。使用高敏肌钙蛋白 T 检测(罗氏 hs-cTnT)在术后第 1 天和第 3 天记录所有纳入患者的肌钙蛋白水平。>15ng/L 被认为异常,称为阳性肌钙蛋白泄漏,而 >100ng/L 被认为疑似急性冠脉综合征(ACS)。
共纳入 160 例患者(n=66 THR、n=55 NoF 髋关节置换术、n=39 TKR)。68 例患者(42%)出现阳性肌钙蛋白泄漏,其中 6 例疑似 ACS。NoF 髋关节置换术患者肌钙蛋白泄漏的患病率最高(62%),其次是 TKR(46%)和 THR(24%)。62 例患者(38%)在第 1 天出现阳性肌钙蛋白水平,53 例患者(33%)在第 3 天出现阳性水平。在存在阳性肌钙蛋白泄漏的情况下确定了重要的患者心脏危险因素,具有缺血性心脏病、高血压、糖尿病、肾脏疾病、年龄 >65 岁和心房颤动的患者统计学上最有可能出现这种情况。
术后肌钙蛋白监测是识别 MINS 风险患者的一种廉价且可靠的方法,可随后增强早期检测、医学优化和转诊策略。简单的干预措施可能会改善预后,并有助于降低 ACS 发生率和及时预防其他并发症。南非(SA)和其他资源有限的发展中国家骨科特定患者中 MINS 的患病率尚不清楚。我们发现阳性肌钙蛋白泄漏率为 42%,这引起了对该问题的认识,我们建议在南非所有关节置换单位常规进行术后肌钙蛋白监测。